LFM
ALXN

Lumina Fund Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Lumina Fund Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-7,000
Closed -$728K – 39
2020
Q1 		$728K Buy
+7,000
New +$687K 0.41% 14
2013
Q4 		– Sell
-3,500
Closed -$403K – 59
2013
Q3 		$403K Buy
+3,500
New +$384K 0.03% 37

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Lumina Fund Management's ALXN Position: Q2 2021 in Review

Lumina Fund Management sold out of Alexion Pharmaceuticals (ALXN) in Q2 2021, closing a stake of 4,100 shares — an estimated $627K sold.

Lumina Fund Management first reported a position in ALXN in Q4 2020 and held it in 2 quarters. The position peaked at $627K in Q1 2021. 708 funds tracked by Wall St. Rank hold ALXN as of Q2 2021.

  • Lumina Fund Management reported no remaining Alexion Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Lumina Fund Management sold 4,100 Alexion Pharmaceuticals shares in Q2 2021, an estimated $627K.
  • Lumina Fund Management first reported a position in Alexion Pharmaceuticals in Q4 2020 and held it in 2 quarters.
  • Lumina Fund Management's Alexion Pharmaceuticals position peaked at $627K in Q1 2021.
  • 708 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2021.

Based on Lumina Fund Management's 13F filing for Q2 2021, filed 13 Aug 2021.